Arkolith/Insider Trading/VKTX/Form 4/A

Rouan Sarah Kathryn

DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4/A · filed Apr 8, 2025
Net Buying
Open-Market Buys
$30K
Open-Market Sells
$0
Net Open-Market Flow
$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2025Buy(P)1K$24.15$30K1K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000950170-25-052255) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML